86
Views
5
CrossRef citations to date
0
Altmetric
Special Report

Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxban

, , , &
Pages 49-58 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sorrel E Wolowacz. (2011) Pharmacoeconomics of dabigatran etexilate for prevention of thromboembolism after joint replacement surgery. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 9-25.
Read now

Articles from other publishers (4)

Christian Wurnig, Andreas Clemens, Helmuth Rauscher, Eva Kleine, Martin Feuring, Reinhard Windhager & Josef Grohs. (2015) Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery. Thrombosis Journal 13:1.
Crossref
Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, Andreas Clemens, Stefan Hantel & Andreas A. Kurth. (2012) Efficacy of delayed thromboprophylaxis with dabigatran: Pooled analysis. Thrombosis Research 130:6, pages 871-876.
Crossref
K Darvall & A Bradbury. (2012) Pathways for venous thromboembolic prophylaxis in medical and surgical patients. Phlebology: The Journal of Venous Disease 27:2_suppl, pages 33-42.
Crossref
Alok Kapoor, Warren Chuang, Nila Radhakrishnan, Kenneth J. Smith, Dan Berlowitz, Jodi B. Segal, Jeffrey N. Katz & Elena Losina. (2012) Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement. PharmacoEconomics 28:7, pages 521-538.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.